Dare Bioscience, Inc. (DARE) — Institutional Holders, Q2 2026
28 institutional investment managers reported a DARE position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $2.7M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
DARE in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- VANGUARD CAPITAL MANAGEMENTAdded · +178,572 sh+$376.8K
- BlackRockAdded · +47,277 sh+$99.8K
- JANE STREET GROUPNew · +36,092 sh+$76.2K
- US BANCORP \DE\Added · +29,550 sh+$62.4K
- VANGUARD FIDUCIARYAdded · +25,331 sh+$53.4K
Biggest sellers
- GEODE CAPITAL MANAGEMENTTrimmed · -37,746 sh-$79.6K
- UBS Group AGTrimmed · -36,553 sh-$77.1K
- XTX Topco LtdSold out · -22,339 sh-$47.1K
- SUSQUEHANNA INTERNATIONAL GROUP, LLPSold out · -17,130 sh-$36.1K
- TWO SIGMA INVESTMENTSSold out · -13,279 sh-$28.0K
DARE 13F holders ranked 1–28 of 28
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT#1 · 640,877 sh | 640,877 | $1.4M | 0.00% | +38.6% |
| 2 | GEODE CAPITAL MANAGEMENT#2 · 140,093 sh | 140,093 | $295.6K | 0.00% | -21.2% |
| 3 | US BANCORP \DE\#3 · 120,920 sh | 120,920 | $255.1K | <0.01% | +32.3% |
| 4 | VANGUARD FIDUCIARY#4 · 91,269 sh | 91,269 | $192.6K | 0.00% | +38.4% |
| 5 | BlackRock#5 · 64,248 sh | 64,248 | $135.6K | 0.00% | +278.6% |
| 6 | STATE STREET#6 · 47,415 sh | 47,415 | $100.0K | 0.00% | +101.6% |
| 7 | JANE STREET GROUP#7 · 36,092 sh | 36,092 | $76.2K | 0.00% | New |
| 8 | NORTHERN#8 · 34,209 sh | 34,209 | $72.2K | 0.00% | +121.7% |
| 9 | HRT FINANCIAL#9 · 22,430 sh | 22,430 | $47.0K | <0.01% | New |
| 10 | Virtu Financial#10 · 15,803 sh | 15,803 | $33.0K | <0.01% | New |
| 11 | LPL Financial#11 · 14,889 sh | 14,889 | $31.4K | 0.00% | +1.7% |
| 12 | RAYMOND JAMES FINANCIAL#12 · 14,864 sh | 14,864 | $31.4K | 0.00% | -3.1% |
| 13 | PRICE T ROWE ASSOCIATES#13 · 13,318 sh | 13,318 | $29.0K | 0.00% | +30.3% |
| 14 | StoneX Group#14 · 11,153 sh | 11,153 | $24.7K | <0.01% | New |
| 15 | Objectivity Squared#15 · 10,915 sh | 10,915 | $23.0K | 0.01% | 0.0% |
| 16 | Farther Finance Advisors#16 · 9,450 sh | 9,450 | $19.9K | — | +1.3% |
| 17 | UBS Group AG#17 · 6,810 sh | 6,810 | $14.4K | 0.00% | -84.3% |
| 18 | Vanguard Global Advisers#18 · 2,940 sh | 2,940 | $6.2K | 0.00% | 0.0% |
| 19 | Bay Harbor Wealth Management#19 · 1,358 sh | 1,358 | $2.9K | <0.01% | New |
| 20 | IFS Advisors#20 · 950 sh | 950 | $2.0K | — | 0.0% |
| 21 | SBI Securities , Ltd.#21 · 645 sh | 645 | $1.4K | — | 0.0% |
| 22 | JONES FINANCIAL COMPANIES LLLP#22 · 396 sh | 396 | $828.00 | 0.00% | New |
| 23 | Caitong International Asset Management , Ltd#23 · 264 sh | 264 | $557.00 | <0.01% | New |
| 24 | BARCLAYS PLC#24 · 248 sh | 248 | $523.00 | 0.00% | New |
| 25 | CALDWELL SUTTER CAPITAL#25 · 100 sh | 100 | $211.00 | <0.01% | +488.2% |
| 26 | MATHER GROUP#26 · 84 sh | 84 | $177.00 | — | -1.2% |
| 27 | Inspire Investing#27 · 14 sh | 14 | $31.00 | — | 0.0% |
| 28 | WELLS FARGO & COMPANY#28 · 0 sh | 0 | $0.00 | 0.00% | New |
Funds that sold out of DARE in Q2 2026 (5)
Held DARE at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| XTX Topco Ltd22,339 sh | 22,339 | $40.7K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP17,130 sh | 17,130 | $31.2K |
| TWO SIGMA INVESTMENTS13,279 sh | 13,279 | $24.2K |
| RENAISSANCE TECHNOLOGIES10,195 sh | 10,195 | $18.6K |
| ROYAL BANK OF CANADA59 sh | 59 | $0.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.